Begin main content

Call for Patient Input and Clinical Experts: Ilumya

Published on: June 11, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Ilumya
Generic name tildrakizumab
Manufacturer Sun Pharma Canada
Indication(s) Psoriasis, moderate to severe plaque
Project Number SR0624-000
Call for patient input 2019-06-11
Patient input deadline 2019-07-31
Submit patient input Submit
Register as Clinical Expert Register